Safety Considerations and Contraindications Who Should Avoid CJC-1295 Ipamorelin Contraindications : Active cancer diagnosis (growth hormone can stimulate existing tumors) Pregnancy or breastfeeding Severe cardiovascular disease Uncontrolled diabetes Children and adolescents under 18 Potential Drug Interactions CJC-1295 Ipamorelin may interact with: Insulin and diabetes medications (can affect blood sugar) Corticosteroids (may blunt GH response) Thyroid medications (may require dose adjustments) Other hormone therapies Medical Supervision Requirements Consult healthcare providers before starting if you have: Diabetes or blood sugar issues Cardiovascular conditions History of cancer Current prescription medications Sleep disorders Our Clinics Experience with CJC-1295 Ipamorelin Dosing Through extensive clinical experience with CJC-1295 Ipamorelin protocols, weve observed optimal results with 200 mcg of each peptide administered before bed, 5 days per week

No, and this is the answer most people are surprised by
If you are local to Laurel, MD, you can book a consultation with Maryland Trim Clinic to review whether GLP-1 therapy fits your medical history and how to personalize your nutrition approach.
Obesity is the primary causal component of CMD [111,112,113,114] (Fig
The right dosage, method of administration, and treatment duration depend on your individual health profile, goals, and any pre-existing conditions